Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL27384096 | 0.97 | DNM1 (0.43) | DNM1OPRM1TSHRLMNAALDH1A1 | |
| Iodide SCHEMBL17431663 | 0.97 | DNM1 (0.43) | DNM1OPRM1TSHRLMNAALDH1A1 | |
| SCHEMBL29531465 | 0.96 | DNM1 (0.47) | DNM1OPRM1TSHRLMNAALDH1A1 | |
| Iodide SCHEMBL27547544 | 0.94 | DNM1 (0.41) | DNM1OPRM1TSHRLMNAALDH1A1 | |
| Iodide SCHEMBL27474337 | 0.94 | DNM1 (0.41) | DNM1OPRM1TSHRLMNAALDH1A1 | |
| Water SCHEMBL553358 | 0.93 | DNM1 (0.45) | DNM1OPRM1TSHRLMNAALDH1A1 | |
| Hydrogen Sulfide SCHEMBL16734975 | 0.93 | DNM1 (0.45) | DNM1OPRM1TSHRLMNAALDH1A1 | |
| Fluoride Ion SCHEMBL15738678 | 0.93 | DNM1 (0.45) | DNM1OPRM1TSHRLMNAALDH1A1 | |
| Bromide SCHEMBL1003648 | 0.93 | DNM1 (0.50) | DNM1OPRM1TSHRLMNAALDH1A1 | |
| Hydrochloric Acid SCHEMBL227335 | 0.93 | DNM1 (0.45) | DNM1OPRM1TSHRLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 727 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713317-A1 | A PROCESS FOR PURIFICATION OF ETHOFUMESATE | Adama Agan Ltd. (IL) | 2026-03-25 | — | — | EP | claimed |
| US-20260076089-A1 | METHOD FOR MANUFACTURING PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTOELECTRIC CONVERSION MATERIAL | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2026-03-12 | — | — | US | claimed |
| US-12492331-B2 | Composite material including COF, heat dissipation/storage member, and method for producing said composite material, and COF single crystal and production method therefor | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2025-12-09 | — | — | US | claimed |
| WO-2025067315-A1 | PROCESS OF REVERSIBLE COMPLEXATION MEDIATED POLYMERIZATION AND PRODUCT OBTAINED THEREFROM | BASF SE (DE) | 2025-04-03 | — | — | WO | claimed |
| WO-2024242064-A1 | METHOD FOR MANUFACTURING PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTOELECTRIC CONVERSION MATERIAL | パナソニックＩＰマネジメント株式会社 | 2024-11-28 | — | — | WO | claimed |
| WO-2024236570-A1 | A PROCESS FOR PURIFICATION OF ETHOFUMESATE | ADAMA AGAN LTD. (IL) | 2024-11-21 | — | — | WO | claimed |
| US-20240309124-A1 | A COMPOSITION AND ITS APPLICATION IN CONTROLLED LIVING WATER-BASED EMULSION POLYMERIZATION | BASF SE (DE) | 2024-09-19 | — | — | US | claimed |
| EP-4377288-A1 | A COMPOSITION AND ITS APPLICATION IN CONTROLLED LIVING WATER-BASED EMULSION POLYMERIZATION | BASF SE (DE) | 2024-06-05 | — | — | EP | claimed |
| EP-4377289-A1 | PROCESS OF PREPARING BLOCK OR GRADIENT COPOLYMERS AND THE COPOLYMER PREPARED THEREOF | BASF SE (DE) | 2024-06-05 | — | — | EP | claimed |
| CN-117751098-A | Method for preparing block or gradient copolymer and copolymer prepared by same | 巴斯夫欧洲公司 | 2024-03-22 | — | — | CN | claimed |
| US-6916951-B2 | Continuous carbonylation process | EASTMAN CHEMICAL COMPANY (US) | 2005-07-12 | — | — | US | claimed |
| WO-2005026095-A1 | PROCESS FOR THE PREPARATION OF ROFLUMILAST | RANBAXY LABORATORIES LIMITED (IN) | 2005-03-24 | — | — | WO | claimed |
| EP-1501779-A1 | CONTINUOUS CARBONYLATION PROCESS | EASTMAN CHEMICAL COMPANY (US) | 2005-02-02 | — | — | EP | claimed |
| WO-2003093211-A1 | CONTINUOUS CARBONYLATION PROCESS | EASTMAN CHEMICAL COMPANY (US) | 2003-11-13 | — | — | WO | claimed |
| US-20030212295-A1 | Continuous carbonylation process | EASTMAN CHEMICAL COMPANY | 2003-11-13 | — | — | US | claimed |
| EP-0749949-B1 | Process for the carbonylation of alkyl alcohols | BP CHEM INT LTD (GB) | 1999-04-14 | — | — | EP | claimed |
| US-5760279-A | USING A STABILIZED RHODIUM CATALYST | BP CHEMICALS LIMITED (GB) | 1998-06-02 | — | — | US | claimed |
| EP-0749949-A1 | Process for the carbonylation of alkyl alcohols | BP Chemicals Limited (GB) | 1996-12-27 | — | — | EP | claimed |
| US-4705897-A | Process for producing bicyclic diamines | TEXACO INC. (US) | 1987-11-10 | — | — | US | claimed |
| US-4333884-A | Production of acetic anhydride | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-06-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076089-A1 | METHOD FOR MANUFACTURING PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTOELECTRIC CONVERSION MATERIAL | CACNA1A, HCN4, SLC9A5 | DNM1 3812/4885OPRM1 4442/4885TSHR 2392/4885 |
| US-20030212295-A1 | Continuous carbonylation process | CA4, CA5B, CA14 | DNM1 2851/4885OPRM1 789/4885TSHR 4418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.